Private Label Tranexamic Acid SPF 30 Face Cream Low MOQ

What concentration of tranexamic acid should be in a face cream?

By Blake Mereby · Last reviewed October 3, 2026

Tranexamic acid (TXA) in topical face creams is most commonly formulated at concentrations between 2% and 5% by weight. This range is supported by the bulk of published dermatological literature and mirrors the concentration used in clinical studies showing statistically significant reduction in melasma severity scores (MASI scores) compared to vehicle control.

The landmark 2012 study by Kanechorn Na Ayuthaya and colleagues showed that a 3% topical tranexamic acid solution applied twice daily produced meaningful improvement in melasma over 12 weeks. Subsequent split-face studies comparing 2% TXA with kojic acid and 4% hydroquinone found TXA to be comparably effective with a better tolerability profile — important for consumers who have experienced irritation from hydroquinone-based brighteners.

From a formulation chemistry standpoint, TXA is water-soluble, which makes it relatively straightforward to incorporate into the aqueous phase of an oil-in-water emulsion. However, a few technical considerations affect the target concentration in a private label product. First, TXA can shift the pH of the emulsion system — cosmetic chemists typically target a finished cream pH of 5.5–6.5 for both skin compatibility and preservative efficacy; TXA tends to push pH upward and may require buffering with citric acid or lactic acid. Second, TXA interacts with some cationic emulsifiers, causing instability — formulators working with TXA at 3–5% should confirm compatibility with their chosen emulsifier system through accelerated stability testing at 45°C for a minimum of 8 weeks before committing to a production batch.

For a product also carrying an SPF 30 claim, the cosmetic chemist must further verify that the TXA doesn't degrade UV filter performance over time. Some chemical filters (particularly avobenzone) are photolabile, and the interaction with TXA in an emulsion matrix should be validated through photostability testing per ISO 24443.

Most private label manufacturers offering a TXA SPF 30 base formula have already conducted this compatibility work at a fixed concentration — commonly 2% or 3% — and can share their stability dataset on request. If you need 5% TXA specifically for a clinical-positioned product, expect a custom formulation fee and additional stability testing time. AJ Cosmo Labs supplier profiles let you filter for manufacturers who already hold validated TXA base formulas, reducing your time-to-market significantly.

Ingredients in this answer: Tranexamic Acid · Kojic Acid · Citric Acid · Lactic Acid · Avobenzone

Read the full guide on Private Label Tranexamic Acid SPF 30 Face Cream Low MOQ →

More about Private Label Tranexamic Acid SPF 30 Face Cream Low MOQ

Tell us about your product

Tell us what you're making. Get an AI-drafted starting formula free, then have a vetted cosmetic chemist check it.

Free to start · no credit card · continue in your browser or the iPhone app.

Have a product idea?

Connect with vetted cosmetic chemists and custom labs on AJ Cosmo Labs.

Get on the App Store Open the web app